Nura Afza Salma Begum

Dr. Nura Afza Salma Begum

Kidney Foundation, Dhaka, Bangladesh
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
TRTanjina Rahman
Tanjina Rahman
Ban-Hock KhorBan-Hock Khor
Ban-Hock Khor
SSSharmela Sahathevan
Sharmela Sahathevan
DKDeepinder Kaur
Deepinder Kaur
ELEno Latifi
Eno Latifi
Pramod KhoslaPramod Khosla
Pramod Khosla
Malnutrition is associated with high rates of mortality among patients with end stage kidney disease (ESKD). There is a paucity of data from Bangladesh, where around 35,000–40,000 people reach ESKD annually. We assessed protein-energy wasting (PEW) amongst 133 patients at a single hemodialysis setting in Dhaka. Patients were 49% male, age 50 ± 13 years, 62% were on twice-weekly hemodialysis. Anthropometric, biochemical, and laboratory evaluations revealed: BMI 24.1 ± 5.2 kg/m2, mid-arm muscle circumference (MAMC) 21.6 ± 3.6 cm, and serum albumin 3.7 ± 0.6 g/dL. Based on published criteria, 18% patients had PEW and for these patients, BMI (19.8 ± 2.4 vs. 25.2 ± 5.2 kg/m2), MAMC (19.4 ± 2.4 vs. 22.2 ± 3.8 cm), serum albumin (3.5 ± 0.7 vs. 3.8 ± 0.5 g/dL), and total cholesterol (135 ± 34 vs. 159 ± 40 mg/dL), were significantly lower as compared to non-PEW patients, while hand grip strength was similar (19.5 ± 7.6 vs. 19.7 ± 7.3 kg). Inflammatory C-reactive protein levels tended to be higher in the PEW group (20.0 ± 34.8 vs. 10.0 ± 13.9 p = 0.065). Lipoprotein analyses revealed PEW patients had significantly lower low density lipoprotein cholesterol (71 ± 29 vs. 88 ± 31 mg/dL, p < 0.05) and plasma triglyceride (132 ± 51 vs. 189 ± 103 mg/dL, p < 0.05), while high density lipoprotein cholesterol was similar. Nutritional assessments using a single 24 h recall were possible from 115 of the patients, but only 66 of these were acceptable reporters. Amongst these, while no major differences were noted between PEW and non-PEW patients, the majority of patients did not meet dietary recommendations for energy, protein, fiber, and several micronutrients (in some cases intakes were 60–90% below recommendations). Malnutrition Inflammation Scores were significantly higher in PEW patients (7.6 ± 3.1 vs. 5.3 ± 2.7 p < 0.004). No discernible differences were apparent in measured parameters between patients on twice- vs. thrice-weekly dialysis. Data from a larger cohort are needed prior to establishing patient-management guidelines for PEW in this population.

31 December 2021 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
HRHarun Ur Rashid
Harun Ur Rashid
NBNura Afza Salma Begum
Nura Afza Salma Begum
TKTasnuva Sarah Kashem
Tasnuva Sarah Kashem
Harun Ur Rashid, Nura Afza Salma Begum, Tasnuva Sarah Kashem. Korean J Transplant 2021;35:208-17. https://doi.org/10.4285/kjt.21.0033

16 June 2024 in Clinical Case Reports
Verified
Journal Article
Open access
ABAmit Bari
Amit Bari
NBNura Afza Salma Begum
Nura Afza Salma Begum
FNFarnaz Nobi
Farnaz Nobi
HRHarun Ur Rashid
Harun Ur Rashid
NANiyoti Akhter
Niyoti Akhter
SISumona Islam
Sumona Islam
Key Clinical Message: The immunomodulatory effect of CMV makes coinfection with other microbes, like VZV possible and potentially deadlier in the post kidney transplant period. Treatment should be started promptly. Both infections can be treated with Valganciclovir. Infections are common complications in kidney transplant recipients owing to the lifelong immunosuppression. Cytomegalovirus (CMV) and Varicella Zoster Virus (VZV) infections are quite common in the posttransplant period. Coinfection with both however has been reported only once. The immunomodulatory effect of CMV makes their interaction with other organisms like VZV potentially sinister. This is a case of a young woman who developed coinfection with HZV and CMV in the first month following a live related kidney transplantation from her mother. Transplant surgery went well with good urine output, but serum creatinine did not fall below 1.7 mg/dL. Immunosuppression consisted of intravenous (IV), followed by oral prednisolone, Mycophenolate Sodium (MPS) and Tacrolimus. 25 days after an uneventful surgery, she developed fever, followed by pain and vesicular eruption on the forehead, typical of VZV infection, along with rising creatinine. CMV PCR yielded 300 copies/mL of DNA, which was undetectable in both donor and recipient pre‐transplant. Total white blood cell count fell to 2 × 109/L. MPS was temporarily stopped. Treatment with Valgancyclovir led to resolution of fever, skin lesions and brought serum creatinine down to baseline over 2 weeks.

30 June 2020 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
TKTerence Kee
Terence Kee
JJJong Cheol Jeong
Jong Cheol Jeong
JHJongwon Ha
Jongwon Ha
HRHarun Ur Rashid
Harun Ur Rashid
NBNura Afza Salma Begum
Nura Afza Salma Begum
DRDevinder Singh Rana
Devinder Singh Rana
The coronavirus disease-19 (COVID-19) pandemic has affected 1,029,968 people in Asia as of May 16, 2020. Although Asia was the first continent to be affected, many countries in the region continue to battle COVID-19, which challenges the way transplant programs provide their services. Given the diversity of healthcare systems in Asia, the countermeasures in response to COVID-19 are as potentially diverse. This review reports the experiences of transplant services in member countries of the Asian Society of Transplantation (AST) as well as provides a platform for sharing of best practices during the COVID-19 pandemic. AST invited member countries to provide a short description of their transplant experiences during the COVID-19 pandemic. Whenever information is available, countries were asked to provide information on COVID-19 related statistics, status of transplant programs, mitigation measures taken to prevent COVID-19, and other areas of transplant programs impacted by COVID-19. Ten countries responded to the invitation of which seven still have active transplant programs at varying levels of activity. All countries have protocols for donor/recipient screening and countermeasures to prevent COVID-19 infections in recipients and healthcare providers. Interestingly, these countries report only 16 transplant recipients with COVID-19 infection but no cases of donor-transmitted COVID-19 infection. Despite the diversity of healthcare systems in Asia, transplant centers in Asia have taken appropriate precautions to avoid COVID-19 infections, though the long-term impact of COVID-19 remains unclear.

30 June 2022 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
NBNura Afza Salma Begum
Nura Afza Salma Begum
TKTasnuva Sarah Kashem
Tasnuva Sarah Kashem
FNFarnaz Nobi
Farnaz Nobi
SAShakib Uz-Zaman Arefin
Shakib Uz-Zaman Arefin
HRHarun Ur Rashid
Harun Ur Rashid
Nura Afza Salma Begum, Tasnuva Sarah Kashem, Farnaz Nobi, Shakib Uz-Zaman Arefin, Harun Ur Rashid. Korean J Transplant 2022;36:111-8. https://doi.org/10.4285/kjt.22.0014

31 December 2021 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
TKTerence Kee
Terence Kee
JJJong Cheol Jeong
Jong Cheol Jeong
HUHarun Ur-Rashid
Harun Ur-Rashid
NBNura Afza Salma Begum
Nura Afza Salma Begum
MAMel hatra I Arakama
Mel hatra I Arakama
GAGhazali Ahmad
Ghazali Ahmad
Terence Kee, Jong Cheol Jeong, Harun Ur-Rashid, Nura Afza Salma Begum, Mel-Hatra Arakama, Romina Danguilan, Lkhaahuu Od-Erdene, Rosnawati Yahya, Yaerim Kim, Hersharan Kaur Sran, Becky Ma, Maggie Ma, Devinder Singh Rana, Curie Ahn, Ghazali Ahmad. Korean J Transplant 2021;35:218-29. https://doi.org/10.4285/kjt.21.0024